41.83MMarket Cap-0.29P/E (TTM)
0.825High0.780Low994.81KVolume0.820Open0.818Pre Close792.50KTurnover3.95%Turnover RatioLossP/E (Static)52.94MShares5.22052wk High0.87P/B19.92MFloat Cap0.43552wk Low--Dividend TTM25.21MShs Float66.960Historical High--Div YieldTTM5.49%Amplitude0.435Historical Low0.796Avg Price1Lot Size
Outset Medical Stock Forum
Outset Medical Announces $169 Million Private Placement Financing From Leading Mutual Funds and Healthcare Institutional Investors
Monday, 6th January at 8:30 am
Secures New Debt Financing of up to $125M Maturing in 2030 with Plans to Retire $200M in Prior Debt
Reports Unaudited Fourth-Quarter Revenue of $29 million and 2024 Revenue of $113 million
SAN JOSE, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (NASDAQ: OM) ("Outset"), a medical technology co...
📊⚡️📊
Larger Image: tradingview.com...
$Outset Medical (OM.US)$
Outset Medical (OM) said Monday that the US Food and Drug Administration has granted 510(k) clearance for TabloCart with prefiltration, an optional accessory to its Tablo Hemodialysis System dialysis machine.
The medical technology company said it has resumed distribution of TabloCart with prefiltration and has product available to ship to customers in the US.
No comment yet